Absence of mutations in the p53 tumor suppressor gene in non-invasive Cushing adenomas.
A lot of evidence supports the existence of a monoclonal origin for pituitary tumors, and several genetic alterations have already been confirmed as necessary or sufficient for unrestrained cellular growth and pituitary function. The p53 gene, a known tumor-suppressor gene (TSG), encodes a protein that exerts antiproliferative effects such as cell-growth arrest and apoptosis in response to several types of stimuli. In fact, several human cancers are believed to be caused by p53 mutations. In the case of pituitary tumors, p53 protein accumulation has been described in ACTH-secreting pituitary adenomas. Since increased amounts of the p53 protein are often related to mutations of its gene, we decided to explore the existence of p53 mutations in the tumor tissues of 9 patients bearing non-invasive corticotropinomas, excised by the transphenoidal route. We screened mutations in exons 5 to 8 of the p53 gene by the PCR-SSCP analysis. We were not able to find any mutation in the exons investigated. Our results are in close accordance with those obtained previously for other types of pituitary tumors.
Copelli
S B
SB
Laboratorio de Endocrinología Molecular, Hospital de Clínicas José de San Martín, Facultad de Medicina, Universidad de Buenos Aires, Argentina. copelli@fend gut.sld.ar
Loza Coll
M A
MA
Bruno
O D
OD
D000236:Adenoma / Q000235:genetics*; D003480:Cushing Syndrome / Q000235:genetics*; D004591:Electrophoresis, Polyacrylamide Gel; D005091:Exons / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics*; D005819:Genetic Markers; D006801:Humans; D009154:Mutation; D018807:Polymorphism, Single-Stranded Conformational
D005819:Genetic Markers